UBS Group’s Edesa Biotech EDSA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.39K Buy
683
+679
+16,975% +$1.38K ﹤0.01% 8304
2025
Q1
$10 Sell
4
-27
-87% -$68 ﹤0.01% 8803
2024
Q4
$52 Buy
31
+27
+675% +$45 ﹤0.01% 8454
2024
Q3
$18 Hold
4
﹤0.01% 8102
2024
Q2
$17 Hold
4
﹤0.01% 8156
2024
Q1
$17 Sell
4
-4,279
-100% -$18.2K ﹤0.01% 7877
2023
Q4
$19.6K Buy
4,283
+3,506
+451% +$16K ﹤0.01% 5913
2023
Q3
$3.44K Buy
777
+772
+15,440% +$3.41K ﹤0.01% 6416
2023
Q2
$27 Sell
5
-810
-99% -$4.37K ﹤0.01% 7579
2023
Q1
$5.2K Buy
815
+810
+16,200% +$5.17K ﹤0.01% 6972
2022
Q4
$71 Hold
5
﹤0.01% 9240
2022
Q3
$0 Sell
5
-152
-97% ﹤0.01% 9315
2022
Q2
$2K Sell
157
-418
-73% -$5.33K ﹤0.01% 8492
2022
Q1
$12K Buy
575
+172
+43% +$3.59K ﹤0.01% 7114
2021
Q4
$16K Sell
403
-364
-47% -$14.5K ﹤0.01% 7032
2021
Q3
$39K Buy
767
+227
+42% +$11.5K ﹤0.01% 5423
2021
Q2
$20K Buy
540
+535
+10,700% +$19.8K ﹤0.01% 6231
2021
Q1
$0 Hold
5
﹤0.01% 7971
2020
Q4
$0 Sell
5
-182
-97% ﹤0.01% 7406
2020
Q3
$11K Sell
187
-270
-59% -$15.9K ﹤0.01% 5880
2020
Q2
$16K Buy
457
+309
+209% +$10.8K ﹤0.01% 5842
2020
Q1
$2K Buy
148
+132
+825% +$1.78K ﹤0.01% 6681
2019
Q4
$0 Sell
16
-164
-91% ﹤0.01% 7041
2019
Q3
$8K Buy
180
+42
+30% +$1.87K ﹤0.01% 6306
2019
Q2
$7K Buy
138
+75
+119% +$3.8K ﹤0.01% 6357
2019
Q1
$3K Sell
63
-257
-80% -$12.2K ﹤0.01% 6493
2018
Q4
$12K Buy
320
+238
+290% +$8.93K ﹤0.01% 6210
2018
Q3
$5K Sell
82
-162
-66% -$9.88K ﹤0.01% 6556
2018
Q2
$18K Buy
244
+222
+1,009% +$16.4K ﹤0.01% 5846
2018
Q1
$5K Buy
22
+5
+29% +$1.14K ﹤0.01% 6329
2017
Q4
$4K Buy
+17
New +$4K ﹤0.01% 6480
2017
Q3
Sell
-17
Closed -$6K 6791
2017
Q2
$6K Buy
+17
New +$6K ﹤0.01% 6093
2017
Q1
Sell
-4
Closed -$2K 6701
2016
Q4
$2K Sell
4
-9
-69% -$4.5K ﹤0.01% 6507
2016
Q3
$9K Sell
13
-2
-13% -$1.39K ﹤0.01% 5921
2016
Q2
$16K Buy
15
+7
+88% +$7.47K ﹤0.01% 5575
2016
Q1
$12K Hold
8
﹤0.01% 5692
2015
Q4
$14K Buy
+8
New +$14K ﹤0.01% 5803